Search details
1.
Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial.
Cancer
; 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-38564338
2.
The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients.
Gastroenterology
; 162(3): 907-919.e10, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34863788
3.
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective.
Langenbecks Arch Surg
; 408(1): 81, 2023 Feb 10.
Article
in English
| MEDLINE | ID: mdl-36763220
4.
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial.
Br J Cancer
; 125(7): 955-965, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34226683
5.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Article
in English
| MEDLINE | ID: mdl-30982686
6.
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease.
Pancreatology
; 20(3): 425-432, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32156527
7.
Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Int J Cancer
; 144(7): 1697-1703, 2019 04 01.
Article
in English
| MEDLINE | ID: mdl-30499151
8.
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Br J Cancer
; 119(2): 170-175, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29961759
9.
Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
Ann Surg Oncol
; 25(8): 2418-2427, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29855828
10.
Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.
Gastric Cancer
; 21(3): 552-568, 2018 May.
Article
in English
| MEDLINE | ID: mdl-28741059
11.
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
Gastric Cancer
; 21(2): 303-314, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-28685209
12.
Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.
Oncology
; 92(5): 291-298, 2017.
Article
in English
| MEDLINE | ID: mdl-28249280
13.
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
BMC Cancer
; 17(1): 509, 2017 Jul 31.
Article
in English
| MEDLINE | ID: mdl-28760152
14.
Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient.
BMC Gastroenterol
; 17(1): 143, 2017 Dec 06.
Article
in English
| MEDLINE | ID: mdl-29207968
15.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27776843
16.
Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction.
BMC Gastroenterol
; 15: 171, 2015 Dec 04.
Article
in English
| MEDLINE | ID: mdl-26637394
17.
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group.
Oncol Res Treat
; 47(1-2): 1-9, 2024.
Article
in English
| MEDLINE | ID: mdl-38167776
18.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
; 42(4): 410-420, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37963317
19.
Burnout among German oncologists: a cross-sectional study in cooperation with the Arbeitsgemeinschaft Internistische Onkologie Quality of Life Working Group.
J Cancer Res Clin Oncol
; 149(2): 765-777, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-35152317
20.
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma.
Oncol Res Treat
; 46(7-8): 320-325, 2023.
Article
in English
| MEDLINE | ID: mdl-37231946